Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients
NCT03678935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-04-17
Summary
The first aim of the study is to investigate the prevalence of persistent gastrointestinal symptoms and compliance with gluten-free diet and the intake of FODMAP in adult celiac patients.
A web-based survey wil be performed and thereafter a randomized controlled trial to test the effect of a FODMAP reduction in patients with celiac disease with irritable bowel-like symptoms.
Conditions
- Celiac Disease
- Irritable Bowel Syndrome
- Diet Modification
- Gluten Sensitivity
Interventions
- OTHER
-
Low FODMAP diet
The intervention group follows the low FODMAP diet for 4 weeks.
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Principal Investigators
-
Knut Lundin, Professor · Oslo University hospital and University of Oslo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2025-07-28
- Completion
- 2025-07-28
Countries
- Norway
Study Locations
More Related Trials
-
Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1
NCT02764931 ·Status: COMPLETED ·Phase: NA
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity
NCT03798249 ·Status: UNKNOWN ·Phase: NA
-
Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 2
NCT02761785 ·Status: COMPLETED
-
Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity
NCT01864993 ·Status: COMPLETED ·Phase: NA
-
Glutenfree, Gut Microbiota and Metabolic Regulation
NCT05135923 ·Status: COMPLETED ·Phase: NA
-
Dose-finding Gluten Challenge Trial in Nonceliac Gluten-sensitivity
NCT03188367 ·Status: UNKNOWN ·Phase: NA
-
Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge
NCT02731976 ·Status: COMPLETED ·Phase: NA
-
Gluten and (Extra-)Intestinal Symptoms in NCGS
NCT05779358 ·Status: COMPLETED ·Phase: NA
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Whole Grain, Gluten-containing Cereal and PROBIOtics to Evaluate Digestive TOLERAance and Immuno-inflammatory Response
NCT04021303 ·Status: UNKNOWN ·Phase: NA
-
Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?
NCT06151782 ·Status: COMPLETED ·Phase: NA
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Dietary Assessment and Mycotoxin Exposure in Celiac Disease
NCT01975155 ·Status: UNKNOWN
-
Non Celiac Gluten Sensitivity, DBPCFC in Adolescents
NCT04639921 ·Status: UNKNOWN ·Phase: NA
-
Detection of Immunotoxic Gluten Peptides in Feces
NCT01478867 ·Status: COMPLETED
-
Celiac Disease Prevention With Probiotics
NCT03176095 ·Status: COMPLETED ·Phase: NA
-
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
NCT02085889 ·Status: UNKNOWN
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
Gluten Free Diet in IBS
NCT04247737 ·Status: COMPLETED ·Phase: NA
-
Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet
NCT05066191 ·Status: UNKNOWN
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics.
NCT02431585 ·Status: UNKNOWN ·Phase: NA
-
Gluten Sensitivity in Non-Celiac Patients
NCT01485341 ·Status: COMPLETED ·Phase: PHASE3
-
Gluten-related Disorders in Familial Mediterranean Fever Patients
NCT03563300 ·Status: COMPLETED ·Phase: NA